Biohaven
BHVN
12.39
-1.26
-9.23%
Biohaven
US · BHVN
#2805 by market cap
Listed 2017
12.39
-1.26
-9.23%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Recent news
-
CCORF Maintains Biohaven(BHVN.US) With Buy Rating, Raises Target Price to $32Market Newswire · 2026/10/30
-
Rating change
RBC Capital Maintains Biohaven(BHVN.US) With Hold Rating, Maintains Target Price $19Market Newswire · 2026/10/17
-
Earnings Flash (BHVN) Biohaven Ltd. Posts Q3 Adjusted Loss $0.73 per Share, Vs. FactSet Est of $-0.78MT Newswires · 2026/10/30
-
Rating change
Citi Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $17Market Newswire · 2026/9/18
-
Rating change
RBC Capital Maintains Biohaven(BHVN.US) With Hold Rating, Maintains Target Price $22Market Newswire · 2026/10/28
-
Company notice
Biohaven: Biohaven Pharmaceutical Holding Company Ltd. - Anticipated Adjustment Option Symbol: BHVN New Symbol: To be determinedOCC · 2022/9/13
-
Rating change
Analysts Offer Insights on Healthcare Companies: Surrozen (SRZN), Gilead Sciences (GILD) and Biohaven Ltd. (BHVN)TipRanks · 2026/10/13
-
BofA Securities Maintains Biohaven(BHVN.US) With Sell RatingMarket Newswire · 2026/10/31
-
Company notice
Biohaven: Biohaven Pharmaceutical Holding Company Ltd. - Contract Adjustment Option Symbol: BHVN New Symbol: BHVN1OCC · 2022/10/3
-
Rating change
RBC Capital Sticks to Its Hold Rating for Biohaven Ltd. (BHVN)TipRanks · 2026/10/23
-
Rating change
J.P. Morgan Maintains Biohaven(BHVN.US) With Buy RatingMarket Newswire · 2026/9/14
-
Rating change
BofA Securities Maintains Biohaven(BHVN.US) With Sell Rating, Maintains Target Price $11Market Newswire · 2026/10/13
-
Rating change
Baird Maintains Biohaven(BHVN.US) With Buy Rating, Cuts Target Price to $48Market Newswire · 2026/10/23
-
Rating change
CCORF Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $21Market Newswire · 2026/10/23
-
Rating change
Biohaven Ltd. (BHVN) Receives a Buy From Canaccord GenuityTipRanks · 2026/10/23
-
Morgan Stanley Maintains Biohaven(BHVN.US) With Buy Rating, Raises Target Price to $21Market Newswire · 2026/11/3
-
Rating change
Analysts' Top Healthcare Picks: Biohaven Ltd. (BHVN), Clover Health Investments (CLOV)TipRanks · 2026/10/9
-
Rating change
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), AxoGen (AXGN) and Biohaven Ltd. (BHVN)TipRanks · 2026/9/30
-
Rating change
RBC Capital Maintains Biohaven(BHVN.US) With Hold Rating, Raises Target Price to $22Market Newswire · 2026/10/23
-
TD Cowen Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $30Market Newswire · 2026/10/30
-
Rating change
Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Boston Scientific (BSX)TipRanks · 2026/9/14
-
Rating change
Raymond James Maintains Biohaven(BHVN.US) With Buy RatingMarket Newswire · 2026/9/10
-
Rating change
Analysts' Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)TipRanks · 2026/8/27
-
CCORF Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $21Market Newswire · 2026/10/9
-
Rating change
Analysts' Opinions Are Mixed on These Healthcare Stocks: Regeneron (REGN), Cytokinetics (CYTK) and Biohaven Ltd. (BHVN)TipRanks · 2026/9/10
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:01:17 · For reference only, not investment advice and not tailored to your situation.
Biohaven discussion 0 comments